Mc-Val-Cit-PAB-Gefitinib chloride | MedChemExpress (MCE)
Mc-Val-Cit-PAB-Gefitinib chloride is a agent-linker conjugates for ADC. Mc-Val-Cit-PAB-Gefitinib chloride consists of Gefitinib (HY-50895) (an EGFR tyrosine kinase inhibitor) and the ADC linker Mc-Val-Cit-PAB[1].
Trivial name | Mc-Val-Cit-PAB-Gefitinib chloride |
Catalog Number | HY-148871 |
Research Area | Cancer |
Purity | 98.69% |
SMILES | COC1=CC2=C(C=C1OCCCN3CCOCC3)C(NC(C=C4)=CC(Cl)=C4F)=NC=[N+]2CC(C=C5)=CC=C5NC([C@H](CCCNC(N)=O)NC([C@H](C(C)C)NC(CCCCCN(C6=O)C(C=C6)=O)=O)=O)=O.[Cl-] |
PubChem Chemical Structure ID | 168007148 |
Size | 5 mg |
Supplier Page | https://www.medchemexpress.com/mc-val-cit-pab-gefitinib-chloride.html |